🇺🇸 FDA
Pipeline program

SP-102

SP-102-03

Phase 3 small_molecule active

Quick answer

SP-102 for Lumbosacral Radicular Pain is a Phase 3 program (small_molecule) at Semnur Pharmaceuticals with 3 ClinicalTrials.gov record(s).

Program details

Company
Semnur Pharmaceuticals
Indication
Lumbosacral Radicular Pain
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials